Mental Health Market is estimated to be US$ 527.44 billion by 2030 with a CAGR of 3.40% during the forecast period


Dynamic internal equilibrium that enables people to make use of their talents in accordance with the common values of society is referred to as Mental Health. It aids in developing empathy for others, expressing and controlling one's own emotions, and dealing with difficult life circumstances. Additionally, it helps with social role-playing and preserving a healthy connection between the body and the mind. However, its imbalance can result in bipolar illness, depression, and anxiety. It may also result in physical discomfort across the body, including the head, back, and stomach. The market is growing as a result of an increase in the prevalence of mental diseases, an increase in the elderly population, and an expansion of awareness campaigns for mental health. The global market for mental health is also expanding as a result of increased education about mental diseases, advocacy work for more human rights respect, and efforts to reduce stigma. However, it is anticipated that the rising expense of mental health programmes and drug usage will restrain market expansion.

Region Analysis:

North America dominates the market during mental health during the forecast period. The expanding requirement among healthcare service providers to better their services to patients who are afflicted with the disease and the growing awareness of mental health are two of the key factors projected to propel market expansion in the area. For instance, the National Alliance on Mental Illness (NAMI) estimates that in the United States, in the year 2020, 1 in 5 persons will experience a mental illness, 1 in 20 will have a serious one, and 1 in 15 will experience both a mental illness and a drug use problem. Additionally, during the COVID-19 epidemic, 26.3 Million adults in the country received virtual mental health care.

Key Highlights:

  • A new technological platform was introduced by international investment company Battery Ventures in February 2021 to assist providers of behavioral health and human services. This system was designed to increase operational effectiveness. It is anticipated that these actions by market participants will increase market size.
  • In fiscal 2022, the U.S. Interior Department will increase spending on firefighting activities by $103 million and develop a good mental health and wellbeing programme for wildland firefighters.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4891

Key Market Insights from the report:

Global Mental Health Market size accounted for US$ 381.98 billion in 2020 and is estimated to be US$ 527.44 billion by 2030 and is anticipated to register a CAGR of 3.40%. The global Mental Health Market is segmented based on disorder, service, age-group and region.

  • Based on Disorder, Mental Health Market is segmented into Schizophrenia, Post-Traumatic Stress Disorder, Depression Anxiety, Bipolar Disorder, Alcohol Use Disorders and Other Disorder.
  • Based on Service, Mental Health Market is segmented into Emergency Mental Health Services, Outpatient Counselling, Inpatient Hospital Treatment Services, Home-Based Treatment Services and Other Services.
  • Based on Age-Group, Mental Health Market is segmented into Pediatric, Adult and Geriatric. 
  • By Region, the Mental Health Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Landscape & their strategies of Mental Health Market:

The key players operating in the Mental Health Market includes being Acadia Healthcare, Ascension Seton, Behavioral Health Network Inc., CareTech Holdings PLC, North Range Behavioral Health, Promises Behavioral Health, Pyramid Healthcare, Strategic Behavioral Health LLC and Sevita (The MENTOR Network).

Comments

Post a Comment

Popular posts from this blog

Global Platelet Rich Plasma Market is estimated to be US$ 1003.06 million by 2030 with a CAGR of 11.50% during the forecast period.

Image
Global Platelet Rich Plasma Market accounted for US$ 337.23 million in 2020 and is estimated to be US$ 1003.06 million by 2030 and is anticipated to register a CAGR of 11.50%. Platelet-rich plasma (PRP), also known as autologous conditioned plasma, is created by extracting red blood cells from blood. When the concentration of platelets in human blood is reduced, platelet-rich plasma is separated, which contains a concentration of platelets above typical values. Platelets thicken the blood and aid in the repair of muscles, ligaments, and tendons. They are extremely high in healing and connective tissue development factors. Platelet-rich plasma (PRP) blends the body's natural ability to heal itself with modern technologies. It has a wide range of medical applications, including neurology, orthopaedics, and ophthalmology. It's also employed in procedures like tendon repair and rotator cuff augmentation. The report   " Global Platelet Rich Plasma Market, By Type (Pure Platelet...
Read more

Neurodegenerative Disorder Therapeutics Market - Improvement in the healthcare infrastructure is likely to create new opportunity for the market

Image
Neurodegenerative Disorder Therapeutics Market   accounted for US$ 9.32 billion in 2019 and is estimated to be US$ 21.3 billion by 2029 and is anticipated to register a CAGR of 8.7% The report " Global  Neurodegenerative Disorder Therapeutics Market, By  Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, and Other Indication Types), By Drug Type (N- methyl- D- aspartate Receptor, Selective Serotonin Reuptake Inhibitor, Dopamine Inhibitors, and Other Drug Types), By Distribution (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy),  and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029” . Key Highlights: In November 2019, Alkermes plc and Rodin Therapeutics, Inc. announced that they have entered into a definitive agreement under which Alkermes will acquire Rodin, a privately held biopharmaceutical company focused ...
Read more

Systemic Lupus Erythematosus Market accounted for US$ 1.87 billion in 2019 and is estimated to be US$ 3.6 billion by 2029 and is anticipated to register a CAGR of 7.0%

Image
  Systemic Lupus Erythematosus (SLE) is the chronic, autoimmune disorder which involves several organ-systems such as kidney, heart, blood, skin, joints, and lungs in most severe cases, brain. In this disease, the human immune system converts hyperactive and attacks the healthy, normal tissues of the body. SLE can often result in symptoms such as malar rash, sub-acute cutaneous lesions, discoid lesions, arthritis, photosensitivity, oral ulcers, serositis, nephropathy, thrombocytopenia, haemolytic anemia, neurologic involvement, fever, thrombosis, Raynaud’s phenomenon, livedo reticularis, and myositis. The global systemic lupus erythematosus market accounted for US$ 1.87 billion in 2019 and is estimated to be US$ 3.6 billion by 2029 and is anticipated to register a CAGR of 7.0%. The report  " Global   Systemic Lupus Erythematosus Market, By Drug Classes (NSAIDs, Corticosteroids, Antimalarials, Immunosuppressants, and Biologics), By Route of Administration (Oral, In...
Read more